با همکاری مشترک دانشگاه پیام نور و انجمن عصب روان‌شناسی

نوع مقاله : مقاله پژوهشی

نویسندگان

1 دانشجوی دکترای تخصصی روانشناسی، گروه روانشناسی، واحد رشت، دانشگاه آزاد اسلامی، رشت، ایران.

2 استادیار گروه روانشناسی، واحد رشت، دانشگاه آزاد اسلامی، رشت، ایران.

3 استادیار گروه روانشناسی, واحد رشت، دانشگاه آزاد اسلامی، رشت، ایران.

4 استاد گروه روانشناسی، واحد رشت، دانشگاه آزاد اسلامی، رشت، ایران.

چکیده


هدف: هدف مطالعه حاضر تعیین اثربخشی درمان ترکیبی شناختی-رفتاری و نوروفیدبک برکاهش عود در سوءمصرف‏کنندگان مواد محرک دارای نشانه‌های افسردگی است. روش: پژوهش نیمه‏ آزمایشی با طرح پیش‌آزمون-پس‌آزمون و دوره پیگیری دو ماهه انجام شد. تمامی مردان سوءمصرف‏ کننده مواد مراجعه ‏کننده به مرکز درمان سوءمصرف مواد سپاهان منطقه 1 شهر تهران در سال 1402 جمعیت آماری پژوهش را تشکیل دادند. با روش نمونه‏ گیری در دسترس و مبتنی بر هدف از بین سوءمصرف‏کنندگان مواد دارای معیارهای ورود به پژوهش تعداد 36 نفر انتخاب و به شیوه تصادفی ‏سازی در 2 گروه 18 نفری (گروه درمان ترکیبی در سوءمصرف‏کنندگان مواد محرک، گروه کنترل در سوءمصرف‏کنندگان مواد محرک) جایگزین شدند. گردآوری داده‏ ها با چک ‏لیست اطلاعات دموگرافیک-فرم محقق‌ساخته، پرسشنامه تجدیدنظر شده افسردگی و پرسشنامه خطر عود مصرف مواد انجام شد. تحلیل داده‏ها با روش‌های آماری، آزمون پیش‏ فرض‏های آمار پارامتریک و آنالیز واریانس با اندازه‌گیری مکرر با نرم‏افزار آماری Spss-v26 انجام شد. یافته‌ها: نتایج نشان داد درمان ترکیبی در آزمودنی‏های گروه آزمایش دو گروه سوءمصرف‏کننده مواد محرک بر کاهش میزان عود مصرف و ابعاد آن (قصد مصرف، مشکلات هیجانی، اجبار در مصرف، فقدان کنترل و انتظار مثبت از مصرف مواد) اثربخش است (05/0>P). نتیجه‌گیری: این مطالعه بیش از پیش نقش سازه ‏های روانی-رفتاری را در مبتلایان به سوءمصرف مواد روشن ساخته و لزوم استفاده از رویکردهای درمانی ترکیبی (شناختی-رفتاری و نوروفیدبک) را به‌منظور تعدیل علائم در مبتلایان به سوءمصرف مواد آشکار می‏سازد.

کلیدواژه‌ها

موضوعات

عنوان مقاله [English]

Investigating the Effectiveness of Combined Cognitive-Behavioral and Neurofeedback Therapy on the Relapse Reduction in Stimulant Substance Abusers with Depressive Symptoms

نویسندگان [English]

  • Soraya Alipoor 1
  • Azar Kiamarsi 2
  • Samereh Asadimojreh 3
  • Bahman Akbari 4

1 PhD student in Psychology, Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran.

2 Assistant Professor, Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran.

3 Assistant Professor, Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran.

4 Professor, Department of Psychology, Rasht Branch, Islamic Azad University, Rasht, Iran.

چکیده [English]

Purpose: The purpose of this study is to determine the effectiveness of combined cognitive-behavioral and neurofeedback therapy on the relapse reduction in stimulant substance abusers with depressive symptoms. Method: A semi-experimental study was conducted with a pre-test-post-test design and a two-month follow-up period. All male substance abusers who were referred to the Sepahan substance abuse treatment center in 1st district of Tehran in 1402 formed the statistical population of the study. With the available and purpose-based sampling method, 36 people were selected from among substance abusers who met the criteria for entering the research and randomly divided into 2 groups of 18 people (combined treatment group for stimulant substance abusers, control group for stimulant substance abusers) were replaced. Data collection was done with demographic information checklist-researcher-made form, revised depression questionnaire and substance abuse relapse risk questionnaire. Data analysis was done with statistical methods, testing the assumptions of parametric statistics and analysis of variance with repeated measurements with statistical software Spss-v26. Findings: The results showed that the combined treatment in the subjects of the experimental group of two groups of stimulant drug abusers is effective in reducing the relapse rate and its dimensions (intention to use, emotional problems, compulsion to use, lack of control and positive expectation of drug use). (P<0.05).  Conclusion: This study further clarified the role of psycho-behavioral structures in substance abuse patients and reveals the necessity of using combined treatment approaches (cognitive

کلیدواژه‌ها [English]

  • "cognitive-behavioral therapy"
  • "combined therapy"
  • " neurofeedback
  • relapse"
  • "stimulants"
Abooie B, S. M., Mardani T. (2023). Comparison of the Effectiveness Combination of CBT and Methadone Therapy wiih MT on Anxiety and Craving Believes in Adolescent. Middle Eastern Journal of Disability Studies.
Albarrán-Cárdenas, L., Silva-Pereyra, J., Martínez-Briones, B. J., Bosch-Bayard, J., & Fernández, T. (2023). Neurofeedback Effects on EEG Connectivity among Children with Reading Disorders: I. Coherence. Applied Sciences, 13(5), 2825.
Bashkirtsev, O., Zimba, O., & Gasparyan, A. Y. (2023). PSYCHOLOGICAL INTERVENTIONS IN THE TIME OF CRISIS. Anti-Aging Eastern Europe, 2(1), 6-8.
Bilevicius, E., Single, A., Bristow, L. A., Foot, M., Ellery, M., Keough, M. T., & Johnson, E. A. (2018). Shame mediates the relationship between depression and addictive behaviours. Addictive behaviors, 82, 94-100.
Ekendahl, M., & Karlsson, P. (2022). A matter of craving–An archeology of relapse prevention in Swedish addiction treatment. International Journal of Drug Policy, 101, 103575.
Fede, S. J., Kisner, M. A., Dean, S. F., Kerich, M., Roopchansingh, V., Diazgranados, N., & Momenan, R. (2023). Selecting an optimal real‐time fMRI neurofeedback method for alcohol craving control training. Psychophysiology, e14367.
Ghaffarzadeh Razaghi MR, H. (2022). Comparison Between the Effectiveness of Cognitive-Behavioral Therapy, Fluoxetine Therapy and Combination Method on Improving Premature Ejaculation Disorder in Opioid Addicts. Health Psychology [Internet], 11(41):83–96. doi:http:..etiadpajohi.ir.article-1-2577-en.html
Kabisa, E., Biracyaza, E., Habagusenga, J. d. A., & Umubyeyi, A. (2021). Determinants and prevalence of relapse among patients with substance use disorders: case of Icyizere Psychotherapeutic Centre. Substance abuse treatment, prevention, and policy, 16(1), 1-12.
Knaus, W. J. (2021). The Cognitive Behavioral Workbook for Anger: A Step-by-step Program for Success: New Harbinger Publications.
Kraus, M. L., Alford, D. P., Kotz, M. M., Levounis, P., Mandell, T. W., Meyer, M., . . . Wyatt, S. A. (2011). Statement of the American Society of Addiction Medicine Consensus Panel on the use of buprenorphine in office-based treatment of opioid addiction. Journal of addiction medicine, 5(4), 254-263.
Li, J., Wang, R., He, J., Wang, L., & Li, L. (2023). Comparison of the effect of hostility on the level of depression of drug addicts and non-addicts and the mediating role of sense of life meaning between them. BMC psychiatry, 23(1), 350.
Liese, B. S., & Beck, A. T. (2022). Cognitive-behavioral therapy of addictive disorders: Guilford Publications.
Magill, M., Kiluk, B. D., & Ray, L. A. (2023). Efficacy of Cognitive Behavioral Therapy for Alcohol and Other Drug Use Disorders: Is a One-Size-Fits-All Approach Appropriate? Substance Abuse and Rehabilitation, 1-11.
Mohammadi Jochi N, N. M. (2020). Getting to know the effects of drugs, stimulants and hallucinogens. Tehran: Mirmah Publications.
N, G. (2021). The effectiveness of alpha.theta neurofeedback in individuals with dependent to morphine and neurofeedback in drug abuse. In: National conference on physical education and sport science with emphasis on physical activity limitation during the covid-19 virus prevalence. Tehran.
Ogai, Y., Haraguchi, A., Kondo, A., Ishibashi, Y., Umeno, M., Kikumoto, H., . . . Aso, K. (2007). Development and validation of the Stimulant Relapse Risk Scale for drug abusers in Japan. Drug and alcohol dependence, 88(2-3), 174-181.
Prior, K., Mills, K., Ross, J., & Teesson, M. (2017). Substance use disorders comorbid with mood and anxiety disorders in the Australian general population. Drug and alcohol review, 36(3), 317-324.
Russo, G. M., Smith, S., & Sperandio, K. R. (2023). A meta‐analysis of neurofeedback for treating substance use disorders. Journal of Counseling & Development, 101(2), 143-156.
Shakerinasab, M., Azimzadeh, T. N., Rostami, T., & Parsa, N. M. (2022). The Effectiveness of Cognitive-Behavioral Therapy Based on Marlatt's Model on Craving and Addiction Quitting Self-Efficacy in Patients under Treatment with Methadone.
Soleimani, E., Nooeipour, R., Khosravian, B., Hasani, A. H., & Hoseinian, S. (2019). Effectiveness of Neurofeedback in Drug Use Craving and Attentional Bias to Drug-related Stimulants in Substance Abusers. Scientific Quarterly Research on Addiction, 12(48), 61-82.
Souilm, N. (2023). Equine-assisted therapy effectiveness in improving emotion regulation, self-efficacy, and perceived self-esteem of patients suffering from substance use disorders. BMC Complementary Medicine and Therapies, 23(1), 363.
Srivastava, A. B., Sanchez‐Peña, J., Levin, F. R., Mariani, J. J., Patel, G. H., & Naqvi, N. H. (2021). Drinking reduction during cognitive behavioral therapy for alcohol use disorder is associated with a reduction in anterior insula‐bed nucleus of the stria terminalis resting‐state functional connectivity. Alcoholism: Clinical and Experimental Research, 45(8), 1596-1606.
Waite, M. R., Heslin, K., Cook, J., Kim, A., & Simpson, M. (2023). Predicting substance use disorder treatment follow-ups and relapse across the continuum of care at a single behavioral health center. Journal of substance use and addiction treatment, 147, 208933.
ZAREI, S. (2022). Parental Marital Conflict And Adolescents Drug Abuse Tendency: The Moderated Model Of Depression And Mindfulness.
Zech, H. G., Reichert, M., Ebner-Priemer, U. W., Tost, H., Rapp, M. A., Heinz, A., . . . Deserno, L. (2022). Mobile data collection of cognitive-behavioral tasks in substance use disorders: where are we now? Neuropsychobiology, 81(5), 438-450.